Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
about
Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems.Lacritin-mediated regeneration of the corneal epithelia by protein polymer nanoparticlesChitosan modification of adenovirus to modify transfection efficiency in bovine corneal epithelial cellsRecent applications of liposomes in ophthalmic drug delivery.Designing polymers with sugar-based advantages for bioactive delivery applicationsLiposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitro.Comparative study on the cytotoxic effects of benzalkonium chloride on the Wong-Kilbourne derivative of Chang conjunctival and IOBA-NHC cell lines.Nanoparticles as protein and gene carriers to mucosal surfaces.Toxicity of therapeutic nanoparticles.Chitosan nanoparticles for drug delivery to the eye.Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.Toxicity of nanomaterials to the eye.Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review).Redefining tissue engineering for nanomedicine in ophthalmology.Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery.Research progress on siRNA delivery with nonviral carriers.Nanomaterials for ocular drug delivery.Ocular application of chitosan.Topical delivery of ocular therapeutics: carrier systems and physical methods.Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions.Skin and muscle permeating antibacterial nanoparticles for treating Staphylococcus aureus infected wounds.Nanocrystal for ocular drug delivery: hope or hype.Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases.Nanoparticles for drug delivery to the anterior segment of the eye.Low molecular weight chitosan-coated liposomes for ocular drug delivery: in vitro and in vivo studies.In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line.Condition responsive nanoparticles for managing infection and inflammation in keratitis.Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.A novel eye drop of alpha tocopherol to prevent ocular oxidant damage: improve the stability and ocular efficacy.Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility.Ocular drug delivery: a clue from nanotechnology.Therapeutic Effect of Cilostazol Ophthalmic Nanodispersions on Retinal Dysfunction in Streptozotocin-Induced Diabetic Rats.Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells.Supercritical fluid-mediated liposomes containing cyclosporin A for the treatment of dry eye syndrome in a rabbit model: comparative study with the conventional cyclosporin A emulsionHyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.Chitosan-coated liposomes for intracellular oligonucleotides delivery: characteristics and cell uptake behavior.On the use of dexamethasone-loaded liposomes to induce the osteogenic differentiation of human mesenchymal stem cells.Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study.Different particulate systems--bypass the biological barriers?
P2860
Q26748776-F07AE7B6-9459-4FC9-A6AA-C1BF6C8807CDQ28118688-67C2930D-1F3E-45B5-8970-58279DB457ACQ28475072-88D66AEC-353A-4337-A66A-1E6CDCA5AE2FQ34734683-39D27550-BC1C-428C-AEFB-956FF97DAD0DQ36307576-DFDB6EF7-1B20-4B5F-956A-F03EDE820A0CQ36498718-B29733DA-B9C8-4368-983F-D4297DF0EBD0Q36499358-CB9B318A-2B02-4931-A130-0CBC004ACF31Q37331802-672FB0E1-B156-4A47-AF1D-09FBEDD8856FQ37385444-9301A8D2-B417-448C-9380-B5F75F2C8643Q37416144-89EE1DC0-B21E-4F67-8672-6705333A3AB9Q37573788-F9380804-7217-4363-8BD7-F04835077649Q37638947-4FB7F090-B741-4B14-9A4A-7988D1AF8BA1Q37676123-439879F4-AAE2-4544-9162-2931046E61E0Q37771030-4F2AA73C-33E2-4403-88D9-0B473287456EQ37782373-FC34A75E-824B-4F89-8058-E9A0BA678AB5Q37804385-D8390B64-B0FD-4F65-9B6A-35C022D1F2D5Q37896464-AE665A12-B1AC-4BBD-8ACE-71F7102E5965Q38003088-F3F204AC-8B5E-45AB-8541-094C50A1F862Q38005199-E3D986C2-D003-4FEA-93B5-BF399B3F84AAQ38196446-267FFE4D-9623-45D3-ABFC-8CC2E4368959Q38227621-613D9826-1460-40A8-B1C6-6255E9CF84ADQ38792301-6F350E1D-09BC-4B3C-B4A8-BE2FE2116254Q38831205-1DB20218-5150-4A2E-898D-1887D8460B08Q38987118-21239B4A-5B16-46A2-9CB1-075F8BBCE2DFQ39230212-1877631F-AC00-4BE4-B07B-850A940B3582Q39445881-74EF358B-54F2-4596-A0A3-249B357DFA77Q39993818-A286408A-8D8A-4E54-92E0-5CFA82EB8B47Q40145775-CF9F122B-D382-439F-8FED-95008AA259EAQ40549525-67BB921B-65BE-4A15-9632-DDFF8D4DD01BQ40573088-1598C213-6A19-44EC-813F-5FA23A55FBF1Q40980060-384EDD71-5158-4A16-86F5-C2D6951D45ACQ41568973-5DBD8555-B5C7-4E96-9A75-D554236DB8AEQ41660571-C7B5A5FB-729D-49E4-BCE6-329871274DE1Q42059207-DB3645D8-D7F7-433C-B537-5251C57A6F02Q42792794-7CBE557C-803C-4084-8E79-10017E81F577Q43234583-6934032C-EE51-4E8F-A003-1776C5ABDA87Q44867756-60DBAB25-BF2C-4AA5-A657-529B4A02CC86Q46876149-B7FE1612-A7AC-4289-AFFB-1D24CE5D60EEQ47447720-D25DB3C3-F30B-4966-A3DF-DE74E208C54AQ48419057-E34E8843-29C3-4612-A61D-9BF3AFF18FF9
P2860
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
@en
type
label
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
@en
prefLabel
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
@en
P2093
P1433
P1476
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
@en
P2093
Begoña Seijo
Edison L S Carvalho
Margarita Calonge
María J Alonso
María Orea
Miguel Jarrín
Victoria Sáez
Yolanda Diebold
P304
P356
10.1016/J.BIOMATERIALS.2006.11.028
P577
2006-12-13T00:00:00Z